Found: 44
Select item for more details and to access through your institution.
Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: Analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction: Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 3, p. 497, doi. 10.1007/s10549-023-07159-9
- By:
- Publication type:
- Article
Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 351, doi. 10.1007/s10549-023-07116-6
- By:
- Publication type:
- Article
A pooled analysis of the cardiac events in the trastuzumab adjuvant trials.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 179, n. 1, p. 161, doi. 10.1007/s10549-019-05453-z
- By:
- Publication type:
- Article
Targeted therapies for solid tumors: is the dream becoming a reality?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Immune Checkpoint Molecules on Tumor-Infiltrating Lymphocytes and Their Association with Tertiary Lymphoid structures in Human Breast cancer.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01412
- By:
- Publication type:
- Article
Adenoid cystic carcinoma of the breast - an aggressive presentation with pulmonary, kidney, and brain metastases: a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Trastuzumab Resistance: Bringing Tailored Therapy to the Clinic.
- Published in:
- Oncology (08909091), 2008, v. 22, n. 11, p. 1259
- By:
- Publication type:
- Article
Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00331-8
- By:
- Publication type:
- Article
Adjuvant Chemotherapy With Sequential or Concurrent Anthracycline and Docetaxel: Breast International Group 02-98 Randomized Trial.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 2, p. 121, doi. 10.1 093/i nci/djm287
- By:
- Publication type:
- Article
Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 3, p. 463, doi. 10.1007/s10549-016-3690-6
- By:
- Publication type:
- Article
Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 143, n. 3, p. 485, doi. 10.1007/s10549-013-2827-0
- By:
- Publication type:
- Article
Pregnancy occurring during or following adjuvant trastuzumab in patients enrolled in the HERA trial (BIG 01-01).
- Published in:
- 2012
- By:
- Publication type:
- Report
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial.
- Published in:
- Breast Cancer Research & Treatment, 2010, v. 119, n. 1, p. 145, doi. 10.1007/s10549-009-0512-0
- By:
- Publication type:
- Article
The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study.
- Published in:
- Breast Cancer Research & Treatment, 2009, v. 116, n. 2, p. 295, doi. 10.1007/s10549-008-0130-2
- By:
- Publication type:
- Article
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0568-1
- By:
- Publication type:
- Article
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Targeted therapies in breast cancer: are heart and vessels also being targeted?
- Published in:
- 2012
- By:
- Publication type:
- journal article
Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Information perception, wishes, and satisfaction in ambulatory cancer patients under active treatment: patient-reported outcomes with QLQ-INFO25.
- Published in:
- Ecancermedicalscience, 2014, v. 8, n. 413-446, p. 1, doi. 10.3332/ecancer.2014.425
- By:
- Publication type:
- Article
How Long is Enough - Optimal Timing of Anti-HER2/neu Therapy in the Adjuvant Setting in Early Breast Cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
New generation of breast cancer clinical trials implementing molecular profiling.
- Published in:
- Cancer Biology & Medicine, 2016, v. 13, n. 2, p. 226, doi. 10.20892/j.issn.2095-3941.2015.0099
- By:
- Publication type:
- Article
Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Erratum to: Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 53, doi. 10.1007/s00280-012-1972-1
- By:
- Publication type:
- Article
CDK4/6 and PI3K inhibitors: A new promise for patients with HER2‐positive breast cancer.
- Published in:
- European Journal of Clinical Investigation, 2021, v. 51, n. 7, p. 1, doi. 10.1111/eci.13535
- By:
- Publication type:
- Article
Pharmacokinetics of Tipifarnib After Oral and Intravenous Administration in Subjects With Advanced Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2006, v. 46, n. 10, p. 1116, doi. 10.1177/0091270006291034
- By:
- Publication type:
- Article
Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel.
- Published in:
- Acta Oncologica, 2020, v. 59, n. 12, p. 1438, doi. 10.1080/0284186X.2020.1809704
- By:
- Publication type:
- Article
Cardiac toxicity with anti-HER-2 therapies: what have we learned so far?
- Published in:
- 2009
- By:
- Publication type:
- journal article
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-023-00610-6
- By:
- Publication type:
- Article
Immunotherapy in breast cancer: an overview of current strategies and perspectives.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00508-3
- By:
- Publication type:
- Article
Survival Impact and Cost‐Effectiveness of a Multidisciplinary Tumor Board for Breast Cancer in Mozambique, Sub‐Saharan Africa.
- Published in:
- Oncologist, 2021, v. 26, n. 6, p. e996, doi. 10.1002/onco.13643
- By:
- Publication type:
- Article
Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience.
- Published in:
- Oncologist, 2013, v. 18, n. 2, p. 134, doi. 10.1634/theoncologist.2012-0342
- By:
- Publication type:
- Article
New Developments in Hormone Receptor-Positive Disease.
- Published in:
- Oncologist, 2011, v. 16, p. 40, doi. 10.1634/theoncologist.2011-S1-40
- By:
- Publication type:
- Article
New Developments in Hormone Receptor--Positive Disease.
- Published in:
- Oncologist, 2011, v. 16, p. 40, doi. 10.1634/theoncologist.2011-S1-40
- By:
- Publication type:
- Article
New Developments in Hormone Receptor--Positive Disease.
- Published in:
- Oncologist, 2010, v. 15, p. 18, doi. 10.1634/theoncologist.2010-S5-18
- By:
- Publication type:
- Article
New Developments in Hormone Receptor-Positive Disease.
- Published in:
- Oncologist, 2010, v. 15, p. 18, doi. 10.1634/theoncologist.2010-S5-18
- By:
- Publication type:
- Article
Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence.
- Published in:
- Journal of Oncology, 2012, p. 1, doi. 10.1155/2012/417673
- By:
- Publication type:
- Article
Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Nonhormonal Systemic Therapy for Advanced Breast Cancer: Do the Math!
- Published in:
- JNCI: Journal of the National Cancer Institute, 2008, v. 100, n. 24, p. 1745, doi. 10.1093/jnci/djn433
- By:
- Publication type:
- Article
The MINDACT trial: The first prospective clinical validation of a genomic tool
- Published in:
- Molecular Oncology, 2007, v. 1, n. 3, p. 246, doi. 10.1016/j.molonc.2007.10.004
- By:
- Publication type:
- Article